Tonix to Present TONMYA Phase 3 Data Analysis at IASP Congress
Tonix Pharmaceuticals says it will present an analysis of Phase 3 data on TONMYA at the IASP 2026 World Congress on Pain.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Tonix Pharmaceuticals says it will present an analysis of Phase 3 data on TONMYA at the IASP 2026 World Congress on Pain.